0.00Open0.10Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover1408.82%IV9.67%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier-7DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.2341Delta0.3976Gamma69.30Leverage Ratio-5.1514Theta0.0000Rho16.23Eff Leverage0.0002Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$